FDA Works To Speed The Advent Of New, More Effective Personalized Medicines
As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the Food and Drug Administration (FDA) today issued a final guidance titled "Pharmacogenomic Data Submissions." Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option...Faster, low cost sequencing technologies needed to drive era of personalized medicine
DNA testing is transforming health care and medicine, but current technologies only give a snapshot of an individual's genetic makeup. Any patient wanting a complete picture of their inherited DNA, or genome, would drop their jaw at the sight of the bill -- to the current tune of $10 million or more charged for every human or mammalian-sized genome sequenced. Now, with a grant award from t...Personalized medicine and technology convergence
It's been one year since the debut of MedTech Futures and it has been a pleasure and a privilege to have the opportunity to share ideas with through this forum. As this column enters its second year, I wanted to take an opportunity to briefly summarize some of the perspectives over the past year and also discuss a topic of great timeliness and importance - namely pe...Advent of New, More Effective and Personalized Medicines
The FDA today issued a final guidance titled "Pharmacogenomic Data Submissions" to speed// development of new medical products through the science of pharmacogenomics. Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option for this individual. This technology has enabled the developm...Treatment of postpartum depression needs to be personalized
In order to provide quick relief from post pregnancy depressions, health care// workers have tried to identify women who may be more vulnerable to this type of depression and taken preventive measures to avoid the condition. However a recent study by the researcher of University of Toronto, Canada who had reviewed 15 randomized control trials on 7,697 women had said that it is possible to prevent...Personalized Treatments For Obesity Planned
The Dietetics and Diet Therapy Unit of the University of Navarra's Ana Anton Solanas has been awarded a fellowship for conducting basic research by the Danone Institute. This will enable Ana Antón Solanas to collaborate in a program// aimed at defining individualized treatments for various types of obesity. This will also enable her to take part in a project targeted at obese women. Th...Personalized Medicine and Innovative Pharmaceuticals
Personalized medicine is creating quite a revolution of sorts. A clue into what might be the norm, years from now, personalized medicines will aim at reducing// or totally obliterating the side-effects by evolving medicines that are tailor –made to a person’s genetic information. Indeed this will be a whole new story in the development of drugs. Amalia M. Issa, a pharmacologist and cli...Personalized Genetics: Unraveling the Secret Code to Good Health.
A path breaking research by American scientists in the area of personalized genetics will soon enable people with the esoteric knowledge of their distinct biological make-up. //This will be possible by scanning and deciphering the genome, and list out an individual’s complete genetic composition. This is indeed a major achievement that can bring about significant improvements in the li...Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
PHILADELPHIA, July 3, 2007 ? Researchers in Slovakia havebeen able to derive mesenchymal stem cells from human adipose, orfat, tissue and engineer them into “suicide genes” that seek out and destroy tumors like tiny homing missiles. This gene therapy approach is a novel way to attack smalltumor metastases that evade current detection techniques andtreatments, the researchers...ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
-- Genotypically Optimized Dosing Results in Improved Toleranceand Evidence of Anticancer Activity -- MELBOURNE, Australia, and MENLO PARK, California U.S.A. June 04,2007-ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announcedtoday the presentation of data from its Quinamed (amonafidedihydrochloride) phase 1/2a dose-escalation study, designed toidentify a genotypically optimis...ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun4, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP)announced today the presentation of data from its Quinamed(R)(amonafide dihydrochloride) phase 1/2a dose-escalation study,designed to identify a genotypically optimised dose of Quinamed inheavily pre-treated patients with a variety of solid tumors. Thekey outcomes f...